Business Daily.
.
The Times Real Estate
A+ R A-

Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its Novel PRM-151 in Development for Fibrotic Diseases

E-mail Print PDF
NEW YORK & LEXINGTON, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its Novel PRM-151 in Development for Fibrotic Diseases

imageimage
Business Daily Media